Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Form Holdings Cp (FH)

Form Holdings Cp (FH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 40,356
  • Shares Outstanding, K 26,550
  • Annual Sales, $ 18,970 K
  • Annual Income, $ -24,010 K
  • 60-Month Beta -0.42
  • Price/Sales 0.79
  • Price/Cash Flow N/A
  • Price/Book 0.72
Trade FH with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.05
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/11/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate -0.12
  • Number of Estimates 1
  • High Estimate -0.12
  • Low Estimate -0.12
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.07 +42.06%
on 12/20/17
1.74 -12.64%
on 12/28/17
+0.36 (+31.03%)
since 12/05/17
3-Month
1.07 +42.06%
on 12/20/17
1.74 -12.64%
on 12/28/17
+0.10 (+7.04%)
since 10/05/17
52-Week
1.07 +42.06%
on 12/20/17
2.60 -41.54%
on 03/08/17
-0.78 (-33.91%)
since 01/05/17

Most Recent Stories

More News
FILAMENT HEALTH ANNOUNCES NEW UNITED STATES PATENT ISSUANCES

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,...

FLHLF : 0.0503 (unch)
FH : 1.52 (+9.35%)
FILAMENT HEALTH ANNOUNCES PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR ADDICTION AND MENTAL HEALTH

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company,...

FLHLF : 0.0503 (unch)
FH : 1.52 (+9.35%)
FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,...

FLHLF : 0.0503 (unch)
FH : 1.52 (+9.35%)
FILAMENT HEALTH TO HOST VIRTUAL INVESTOR UPDATE

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,...

FLHLF : 0.0503 (unch)
FH : 1.52 (+9.35%)
FILAMENT HEALTH AND ATMA JOURNEY CENTERS ANNOUNCE 14 SUBJECTS DOSED IN HEALTH CANADA-APPROVED PSILOCYBIN CLINICAL TRIAL

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company,...

FLHLF : 0.0503 (unch)
FH : 1.52 (+9.35%)
FILAMENT HEALTH APPOINTS NEW MEMBERS TO BOARD OF DIRECTORS AND ADVISORY COUNCIL

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company,...

FLHLF : 0.0503 (unch)
FH : 1.52 (+9.35%)
FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,...

FLHLF : 0.0503 (unch)
FH : 1.52 (+9.35%)
FILAMENT HEALTH ANNOUNCES PARTICIPATION IN PROJECT SOLACE

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company,...

FLHLF : 0.0503 (unch)
FH : 1.52 (+9.35%)
FILAMENT HEALTH ANNOUNCES CLOSING OF $2,500,080 PRIVATE PLACEMENT

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,...

FLHLF : 0.0503 (unch)
FH : 1.52 (+9.35%)
FILAMENT HEALTH ISSUED THIRD PATENT BY UNITED STATES PATENT AND TRADEMARK OFFICE

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,...

FLHLF : 0.0503 (unch)
FH : 1.52 (+9.35%)

Business Summary

FORM Holdings Corp. is a diversified holding company. The Company specializes in identifying, investing in and developing companies with growth potential. FORM Holdings Corp., formerly known as Vringo Inc., is based in New York.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.65
1st Resistance Point 1.58
Last Price 1.52
1st Support Level 1.42
2nd Support Level 1.33
3rd Support Level N/A

See More

52-Week High 2.60
Fibonacci 61.8% 2.02
Fibonacci 50% 1.84
Fibonacci 38.2% 1.65
Last Price 1.52
52-Week Low 1.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar